Exclusive worldwide supplier of BioCell Collagen II® files suit to protect its intellectual property rights and to protect consumers as demand for ingredient accelerates nationally
ANAHEIM, CA, October 7, 2004 - BioCell Technology, LLC, exclusive worldwide supplier of BioCell Collagen II®, has filed suit against Cyvex Nutrition, Inc. this week for alleged infringement of several of its key patents. BioCell Technology has pioneered a novel dietary supplement derived from sternum cartilage known as BioCell Collagen II®.
According to the suit, Cyvex Nutrition has offered for sale, sold, and continues to make, use and offer for sale Chicken Collagen Type II material containing Chondroitin Sulfate and Hyaluronic Acid that infringes on BioCell Technology's patents.
BioCell Collagen II® is a leading ingredient supported by scientific research, patents and safety studies. “We have invested in science and consumer education to validate and market this ingredient and its demand is rapidly growing because of our diligent efforts. Consumers have a right to know the exact composition and quality of the dietary supplement products they are purchasing to ensure maximum health benefits. We will take every necessary step to protect our company and product reputation,” said Suhail Ishaq, vice president of BioCell Technology, LLC.
According to Ishaq, BioCell Technology’s BioCell Collagen II®, which is a rich source of bioavailable Hyaluronic Acid, is a revolutionary ingredient that provides the body with "tissue specific dietary ingredient" for maximum nutritional support.
“The most common structural protein in the body is collagen, and BioCell Collagen II® is the ultimate collagen dietary ingredient. By supplying the body with key collagen building blocks such as Collagen Type II, Chondroitin Sulfate, Hyaluronic Acid and a unique Amino Acid profile, BioCell Collagen II® provides nutritional support that no other ingredient can offer,” said Ishaq.
BioCell Collagen II® is widely used by BioCell Technology’s marketing partners in products providing nutritional support and promoting: Healthy Active Joints*, Healthy Young Looking Skin*, Healthy Strong Connective Tissue* and Healthy Cardiovascular System*. Since its discovery, BioCell Technology has extensively invested in the efficacy, safety, and pharmacokenetic research that substantiate and establish BioCell Collagen II® as the gold standard in Hyaluronic Acid and Collagen supplementation.
For more information on BioCell Collagen II® science and patents visit www.biocelltechnology.com.
Founded in 1997, BioCell Technology, LLC pioneered the applications of Sternum Collagen Type II, the highest concentrated natural source available of type II collagen. It is the exclusive supplier of BioCell Collagen II®. BioCell Technology, LLC owns the exclusive rights to market BioCell Collagen II® under the United States Patent #6,025,327, #6,323,319 and #6,780,841. BioCell Collagen II® is a branded registered logo that is available for display on its client’s labels to market under their own brand name or formulas. For more information on BioCell Collagen II®, please contact Asma Ishaq at BioCell Technology, LLC at (714) 632-1231, or visit them at www.biocelltechnology.com.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure, treat, or prevent any disease.